Scientific Reports, 2025 Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy Zhang R., Chang R., Wang H. et al. Olink Target 96Metabolic DiseasesNephrologyPathophysiologySerum | | | | |
Cell Death Discovery, 2025 Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells Hajikhezri Z., Zygouras I., Sönnerborg A. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyCell Culture Supernatant | | | | |
Translational Vision Science & Technology, 2025 Genetics of Circulating Inflammatory Proteins and Iridocyclitis: An Exploratory Mendelian Randomization Study Liu H., Li F., Wang F. et al. Olink Target 96Immunological & Inflammatory DiseasesOphthalmologyPathophysiologyPlasma | | | | |
Nature Cardiovascular Research, 2025 Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction Rasooly D., Giambartolomei C., Peloso G. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
eBioMedicine, 2025 Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation Michaëlsson K., Zheng R., Baron J. et al. Olink Target 96Olink Explore 3072/384CVDAgingPathophysiologyPatient StratificationPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2025 Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights Wang X., Tian H., Chi Z. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerum | | | | |
ImmunoTargets and Therapy, 2025 Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy Ke C., Yu Y., Li J. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesOphthalmologyPathophysiologyPlasma | | | | |
Movement Disorders, 2025 Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [11C]PBR28 PET Wallin J., Forsberg A., Svenningsson P. Olink Target 96NeurologyPathophysiologyPlasmaCSF | | | | |
International Journal of Chronic Obstructive Pulmonary Disease, 2025 The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD Yan K., Wang Y., Xin P. Olink Target 96Respiratory DiseasesPathophysiologyPlasma | | | | |
Brain Communications, 2025 An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis van Eijk R., Steyn F., Janse van Mantgem M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Journal of Stroke and Cerebrovascular Diseases, 2025 Exploring the bidirectional relationships between alzheimer's disease and cerebral small vessel disease: Insights from mendelian randomization Shang H., Liu T., Gong W. et al. Olink Target 96CVDNeurologyPathophysiologyPlasma | | | | |
Frontiers in Endocrinology, 2025 Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid Wang C., Feng Y., Chen Y. et al. Olink Target 96ObstetricsPatient StratificationSerumFollicular Fluid | | | | |
Nature Communications, 2025 Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia Sklavenitis-Pistofidis R., Konishi Y., Heilpern-Mallory D. et al. Olink Target 48OncologyPathophysiologyPlasma | | | | |
Nature Genetics, 2025 Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups Hoffmann T., Graff R., Madduri R. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Pediatric Research, 2025 Gut microbiota, inflammatory cytokines, and Kawasaki disease: a Mendelian randomization study and mediation analysis Wang J., Dou H., Liang Q. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
PROTEOMICS, 2025 Comparative Analysis Between Olink‐PEA and Alamar‐NULISA Proteomic Technologies Applied to a Critically Ill COVID‐19 Cohort Taleb S., Stephan N., Chennakkandathil S. et al. Olink Target 96Wider Proteomics StudiesInfectious DiseasesTechnology EvaluationCross-platform ValidationPlasma | | | | |
Children, 2025 Novel Inflammatory Biomarkers for Autism Spectrum Disorder Detected by Plasma Olink Proteomics Lv T., Wang M., Kui L. et al. Olink Target 96NeurologyPatient StatificationPlasma | | | | |
Cytokine, 2025 A pilot investigation on inflammatory markers and theta burst stimulation protocol interaction along a three-month recovery course following an isolated upper limb fracture Robitaille B., Herrero Babiloni A., Jodoin M. et al. Olink Explore 3072/384Other Diseases & SyndromesPathophysiologySerum | | | | |
Critical Care Medicine, 2025 Host Response Stratification in Malarial and Non-malarial Sepsis: A Prospective, Multicenter Analysis From Uganda Cummings M., Lutwama J., Owor N. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
Nature, 2025 Genetic architecture in Greenland is shaped by demography, structure and selection Stæger F., Andersen M., Li Z. et al. Olink Target 96Wider Proteomics StudiesPathophysiologyPlasma | | | | |